Karlsson P - Search Results

1

Elevated cyclin B2 expression in invasive breast carcinoma is associated with unfavorable clinical outcome.

Shubbar E, Kovács A, Hajizadeh S, Parris TZ, Nemes S, Gunnarsdóttir K, Einbeigi Z, Karlsson P, Helou K. Shubbar E, et al. Among authors: karlsson p. BMC Cancer. 2013 Jan 2;13:1. doi: 10.1186/1471-2407-13-1. BMC Cancer. 2013. PMID: 23282137 Free PMC article.

2

Clustering of individuals with both breast and ovarian cancer--a possible indicator of BRCA founder mutations.

Einbeigi Z, Meis-Kindblom JM, Kindblom LG, Wallgren A, Karlsson P. Einbeigi Z, et al. Among authors: karlsson p. Acta Oncol. 2002;41(2):153-7. doi: 10.1080/028418602753669526. Acta Oncol. 2002. PMID: 12102159

3

A high frequency of germline BRCA1/2 mutations in western Sweden detected with complementary screening techniques.

Bergman A, Flodin A, Engwall Y, Arkblad EL, Berg K, Einbeigi Z, Martinsson T, Wahlström J, Karlsson P, Nordling M. Bergman A, et al. Among authors: karlsson p. Fam Cancer. 2005;4(2):89-96. doi: 10.1007/s10689-004-5812-2. Fam Cancer. 2005. PMID: 15951958

4

Occurrence of both breast and ovarian cancer in a woman is a marker for the BRCA gene mutations: a population-based study from western Sweden.

Einbeigi Z, Bergman A, Meis-Kindblom JM, Flodin A, Bjursell C, Martinsson T, Kindblom LG, Wahlström J, Wallgren A, Nordling M, Karlsson P. Einbeigi Z, et al. Among authors: karlsson p. Fam Cancer. 2007;6(1):35-41. doi: 10.1007/s10689-006-9101-0. Fam Cancer. 2007. PMID: 16944270

5

Comparative genome hybridization reveals specific genomic imbalances during the genesis from benign through borderline to malignant ovarian tumors.

Helou K, Padilla-Nash H, Wangsa D, Karlsson E, Osterberg L, Karlsson P, Ried T, Knutsen T. Helou K, et al. Among authors: karlsson p, karlsson e. Cancer Genet Cytogenet. 2006 Oct 1;170(1):1-8. doi: 10.1016/j.cancergencyto.2006.04.010. Cancer Genet Cytogenet. 2006. PMID: 16965948

6

Chromosomal changes associated with clinical outcome in lymph node-negative breast cancer.

Karlsson E, Danielsson A, Delle U, Olsson B, Karlsson P, Helou K. Karlsson E, et al. Among authors: karlsson p. Cancer Genet Cytogenet. 2007 Jan 15;172(2):139-46. doi: 10.1016/j.cancergencyto.2006.09.019. Cancer Genet Cytogenet. 2007. PMID: 17213022

7

Gene expression variation to predict 10-year survival in lymph-node-negative breast cancer.

Karlsson E, Delle U, Danielsson A, Olsson B, Abel F, Karlsson P, Helou K. Karlsson E, et al. Among authors: karlsson p. BMC Cancer. 2008 Sep 8;8:254. doi: 10.1186/1471-2407-8-254. BMC Cancer. 2008. PMID: 18778486 Free PMC article.

8

Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA).

Osorio A, Milne RL, Pita G, Peterlongo P, Heikkinen T, Simard J, Chenevix-Trench G, Spurdle AB, Beesley J, Chen X, Healey S; KConFab; Neuhausen SL, Ding YC, Couch FJ, Wang X, Lindor N, Manoukian S, Barile M, Viel A, Tizzoni L, Szabo CI, Foretova L, Zikan M, Claes K, Greene MH, Mai P, Rennert G, Lejbkowicz F, Barnett-Griness O, Andrulis IL, Ozcelik H, Weerasooriya N; OCGN; Gerdes AM, Thomassen M, Cruger DG, Caligo MA, Friedman E, Kaufman B, Laitman Y, Cohen S, Kontorovich T, Gershoni-Baruch R, Dagan E, Jernström H, Askmalm MS, Arver B, Malmer B; SWE-BRCA; Domchek SM, Nathanson KL, Brunet J, Ramón Y Cajal T, Yannoukakos D, Hamann U; HEBON; Hogervorst FB, Verhoef S, Gómez García EB, Wijnen JT, van den Ouweland A; EMBRACE; Easton DF, Peock S, Cook M, Oliver CT, Frost D, Luccarini C, Evans DG, Lalloo F, Eeles R, Pichert G, Cook J, Hodgson S, Morrison PJ, Douglas F, Godwin AK; GEMO; Sinilnikova OM, Barjhoux L, Stoppa-Lyonnet D, Moncoutier V, Giraud S, Cassini C, Olivier-Faivre L, Révillion F, Peyrat JP, Muller D, Fricker JP, Lynch HT, John EM, Buys S, Daly M, Hopper JL, Terry MB, Miron A, Yassin Y, Goldgar D; Breast Cancer Family Registry; Singer CF, Gschwantler-Kaulich D, Pfeiler G, Sp… See abstract for full author list ➔ Osorio A, et al. Br J Cancer. 2009 Dec 15;101(12):2048-54. doi: 10.1038/sj.bjc.6605416. Epub 2009 Nov 17. Br J Cancer. 2009. PMID: 19920816 Free PMC article.

9

BRCA1 gene mutations may explain more than 80% of excess number of ovarian cancer cases after breast cancer - a population based study from the Western Sweden Health Care region.

Einbeigi Z, Enerbäck C, Wallgren A, Nordling M, Karlsson P. Einbeigi Z, et al. Among authors: karlsson p. Acta Oncol. 2010 Apr;49(3):361-7. doi: 10.3109/02841860903521095. Acta Oncol. 2010. PMID: 20151938

10

High-resolution genomic profiling to predict 10-year overall survival in node-negative breast cancer.

Möllerström E, Delle U, Danielsson A, Parris T, Olsson B, Karlsson P, Helou K. Möllerström E, et al. Among authors: karlsson p. Cancer Genet Cytogenet. 2010 Apr 15;198(2):79-89. doi: 10.1016/j.cancergencyto.2009.12.012. Cancer Genet Cytogenet. 2010. PMID: 20362222

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

550 results

Search Page

Filters